Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Atossa Therapeutics, Inc. Common Stock (ATOS)
Atossa Therapeutics, Inc. Common Stock
XNAS:ATOS
0.81
5.99%

Ask
$0.86 - 2,500.00
Bid
$0.69 - 5,000.00
Low
$0.77
High
$0.81
Open
$0.78
Prev Close
$0.76
52W High
1.3
52W Low
0.55
Volume
844277
Avg Vol (3m)
662818.5
Float
129124498.44
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 11/08/2012
Primary Exchange: XNAS

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Phone: 206.588.0256
Address: 10202 5th Avenue Ne
Address 2: Suite 200
City: Seattle
State: WA
Postal Code: 98125
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
13
P/E (TTM)
-3.410000
P/B (TTM)
2.073790
EPS
-0.07
Round Lot
100
Composit FIGI
BBG002NCD8C8
Share Class FIGI
BBG002NCD954
Share Class Shares Outstanding
129.17M
Weighted Shares Outstanding
129.17M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own ATOS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.